Altogether, these results indicate that DYRK1A undergoes a proteolytic processing in human AD hippocampus leading to the decrease of DYRK1AFL and the accumulation of DYRK1AT thus confirming previous study. Here, DYRK1A is linked to Alzheimer disease.